The veterinary antibiotics market has seen considerable growth due to a variety of factors.
• Over the last few years, there has been a significant expansion in the size of the veterinary antibiotics market. It is projected to increase from $2.47 billion in 2024 to $2.72 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%.
The substantial growth observed in the historic period is due to the rise in pet expenditure and the scarcity of generic drugs.
The veterinary antibiotics market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of veterinary antibiotics is anticipated to experience significant expansion in the coming years. It's predicted to reach $3.98 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.9%.
The expected escalation during the projection period is due to a rise in pet insurance penetration, growth in pet ownership, enhancement in government initiatives, and an increase in knowledge about animal health. The forecast period sees major trends such as strategic alliances and partnerships, the innovation of new chewable medicines, combined parasite treatments, improved arthritis therapies and the manufacturing of generic drugs for animal care.
The rise in zoonotic diseases is a key factor propelling the growth of the veterinary antibiotics market. Zoonotic diseases, caused by invisible microbes, infections, and parasites, transmit from animals to humans. Major zoonotic pathogens like salmonella and campylobacter inhabit the intestines of animals. These diseases pose a significant risk to humans as they can be transferred through the food chain. Research conducted by FoodNet (Centers for Disease Control and Prevention, USA) reveals that zoonotic diseases lead to 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths. Also, the highest rate of incidences per 100,000 individuals in the USA is due to infectious diseases such as campylobacter, salmonella, and shigella. Thus, an urgency to detect these diseases in animals at an early stage significantly drives the veterinary antibiotics market.
The veterinary antibiotics market covered in this report is segmented –
1) By Product: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others
2) By End User: Farm Animals , Companion Animals
3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Others
Subsegments:
1) Anti-Parasitic: Endoparasiticides, Ectoparasiticides
2) Anti-Bacterial: Tetracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides
3) Non-Steroidal Anti-Inflammatory Drug (Nsaid): Carprofen, Meloxicam, Aspirin
4) Others: Antifungal, Antiviral
A rising trend in the veterinary antibiotics market is the growing partnership between corporations. Merging technology and diverse product types becomes possible through such collaborations, further enhancing the quality and production pace of the antibiotics. As a result, companies in this market are shifting their focus towards collaborative efforts. For example, GlobalVetLink, a U.S-based company that provides software services and informatics solutions for animal health, teamed up with Veterinary Innovative Partners in September 2022. Their project involved the installation of the GlobalVetLink Compliance Assistant, a comprehensive SaaS platform designed to streamline animal health.
Major companies operating in the veterinary antibiotics market include:
• Boehringer Ingelheim GmbH
• Zoetis. Inc.
• Merck & Co.. Inc.
• Elanco Animal Health Incorporated
• Vetoquinol S.A.
• Phibro Animal Health Corporation
• Kyoritsu Seiyaku Corporation
• Dechra Pharmaceuticals plc
• Bayer Animal Health China
• China Animal Healthcare Ltd.
• China Animal Husbandry Industry Corporation Ltd. (CAHIC)
• Guangdong Wens Dahuanong Biotechnology Co. Ltd.
• IDEXX Laboratories
• Merial Pulike Biological Engineering
• Ceva Santé Animale
• Nimrod Veterinary Products Ltd.
• Bimeda
• VIRBAC SA
• Orion Animal Health
• Laboratorios Calier
• SA
• Petmedix
• Eco Animal Health
• Teknofarma
• Farmavet
• Candioli Pharma
• Suanfarma
• Marino Ibericamed
• MPA veterinary
• Lamons Laboratories SA
• SUPER'S DIANA
• Swetrade Pharmaceuticals AB
• Animalcare
• VIC Animal Health
• AVZ animal health
• Provet Group
• VitOMEK LCC
• Micro-plus
• Biowet
• Bioveta
• Brovapharma
• Evrovet
• Ukrvetprompostach
• VELELEK d.o.o
• Veterinarski Zavod Subotica
• VetPlanet
• Delos Medica
• Vetro Solutions
• Belfarmacom
• IDT Biologika
• UCBVET
• Syntec
• Sauvet
• Vetanco
• Chemo Argentina
• Brouwer
• Agrovet Market Animal Health
• Lemavet
• Saudi Pharmaceutical Industries (SPI)
• DBK Pharma S.A.E.
North America was the largest region in the veterinary antibiotics market in 2024. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa